-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$65.67534.49% Upside
Enanta Pharmaceuticals, Inc. Frequently Asked Questions
-
What analysts cover Enanta Pharmaceuticals, Inc.?
Enanta Pharmaceuticals, Inc. has been rated by research analysts at H.C. Wainwright, RBC Capital, Piper Sandler in the past 90 days.